USD91.63 ₽ EUR98.76 ₽ telegram Telegram
2024-03-13 обновлены отчеты компании SGMO: 202320222021
Sangamo Therapeutics logo
Sangamo Therapeutics SGMO
$ 0.52 4.18%

Sangamo Therapeutics Мультипликаторы 2011-2024 | SGMO

Мультипликаторы по годам Sangamo Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.5 -0.6 -6.1 -15.2 -8.5 -16.4 -30.0 -3.5 -10.4 -32.4 -41.9 -22.6 -4.7

P/S

0.8 1.1 9.8 15.5 7.9 13.3 44.7 12.9 10.7 18.7 46.2 23.2 16.2

EPS

-1.5 -1.2 -1.2 -0.9 -0.8 -0.7 -0.7 -1.0 -0.6 -0.4 -0.5 -0.4 -0.7

EV (Enterprise Value)

175 млн 289 млн 1.25 млрд 2.15 млрд 934 млн 1.21 млрд 1.68 млрд 250 млн 377 млн 888 млн 1.12 млрд 499 млн 157 млн

EBITDA per Share

-1.48 -1.23 -1.2 -0.864 -0.852 -0.772 -0.703 -1.01 -0.658 -0.388 -0.466 -0.408 -0.696

EV/EBITDA

-6.8 -14.7 -7.6 -13.1 -28.9 -3.2 -7.7 -32.7 -42.3 -22.4 -4.3

PEG

-0.04 -0.05 -1.02 0.56 0.4 16.75 -0.96 0.05 0.21 -1.73 2.93 -0.55 0.16

P/B

1.7 0.4 2.9 3.7 1.9 3.1 8.7 1.8 2.2 4.1 9.2 7.8 2.1

P/CF

-0.6 -0.5 -4.6 11.8 -4.9 -190.0 220.2 -3.8 -11.7 -136.2 -56.0 -57.1 -6.3

ROE %

-311.06 -65.19 -47.50 -24.28 -22.01 -18.64 -29.04 -52.61 -21.15 -12.78 -21.87 -34.31 -44.61

ROA %

-155.96 -34.18 -24.70 -12.89 -14.93 -11.57 -19.03 -45.38 -18.74 -10.86 -18.90 -26.98 -40.93

ROCE %

-330.58 -68.24 -48.85 -16.30 -18.53 -15.07 -23.30 -50.18 -23.77 -11.94 -20.39 -30.10 -44.70

Current Ratio

2.0 2.1 2.1 4.6 5.8 5.2 5.5 11.3 10.6 9.1 9.6 7.8 11.9

DSO

4.8 15.9 18.5 19.3 134.0 21.8 35.8 97.8 26.1 85.9 52.8 72.8 44.2

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Операционный цикл

4.8 15.9 18.5 - - - - - - - - - -

Финансовый цикл

4.8 15.9 18.5 - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Sangamo Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.59 -0.66 0.13 - -0.34 -0.29 -0.3 - -0.33 -0.33 -0.32 -0.29 -0.01 -0.26 -0.37 0.04 -0.24 -0.26 -0.41 -0.18 -0.13 -0.17 -0.23 -0.15 -0.15 -0.17 -0.23 -0.14 -0.27 -0.38 -0.23 -0.2 -0.13 -0.17 -0.08 -0.06 -0.11 -0.1 -0.12 -0.13 -0.11 -0.1 -0.13 -0.07 -0.11 -0.11 -0.14 -0.12 -0.18 -0.2 -0.21

EBITDA per Share

- - 0.13 - -0.29 -0.31 -0.29 - -0.29 -0.34 -0.31 - - -0.25 -0.37 - -0.23 -0.28 -0.42 - -0.14 -0.18 -0.24 - -0.14 -0.17 -0.23 - -0.26 -0.37 -0.23 - -0.17 -0.17 -0.09 - -0.11 -0.1 -0.12 - -0.1 -0.1 -0.13 - -0.1 -0.1 -0.14 - -0.17 -0.19 -0.18

ROE %

-137.11 -77.10 -41.65 -43.90 -55.65 -50.20 -47.23 -32.10 -40.25 -28.82 -25.44 -24.28 -15.08 -21.08 -20.87 -22.01 -28.15 -25.34 -22.88 -18.64 -20.52 -23.59 -25.70 -29.04 -29.14 -36.49 -49.36 -52.61 -52.83 -43.71 -30.50 -21.15 -15.96 -14.81 -11.88 -12.78 -17.39 -18.78 -19.88 -21.87 -20.54 -24.42 -28.76 -34.31 -36.88 -39.88 -43.86 -44.61 -11.92 -12.80 -11.95

ROA %

-86.79 -48.33 -19.82 -22.39 -28.57 -19.07 -24.72 -17.06 -21.38 -15.37 -13.56 -12.89 -7.85 -11.97 -12.89 -14.93 -18.81 -16.70 -14.77 -11.57 -12.98 -15.11 -16.65 -19.03 -20.56 -28.26 -40.74 -45.38 -45.74 -37.98 -26.73 -18.74 -14.06 -12.91 -10.20 -10.86 -14.87 -16.13 -17.13 -18.90 -17.34 -19.99 -23.06 -26.98 -30.04 -33.97 -38.77 -40.93 -10.94 -11.75 -10.97

ROCE %

-144.14 -83.03 -44.51 -45.66 -57.58 -51.76 -48.32 -32.71 -33.45 -22.26 -18.94 -17.29 -24.05 -30.07 -30.20 -24.66 -29.09 -26.76 -24.23 -15.38 -22.32 -24.83 -26.40 -22.67 -36.77 -43.94 -56.85 -46.06 -52.65 -45.14 -31.81 -16.20 -19.91 -17.02 -14.05 -10.80 -15.86 -17.21 -18.30 -15.23 -24.17 -28.05 -32.41 -29.01 -40.96 -43.97 -47.95 -36.76 -11.95 -12.83 -11.98

Current Ratio

2.6 3.6 4.2 2.1 2.1 - 2.0 2.1 2.1 2.1 2.1 2.1 2.1 2.1 2.1 3.1 3.1 3.1 3.1 2.6 2.6 2.6 2.6 2.9 2.9 2.9 2.9 7.3 7.3 7.3 7.3 8.8 8.8 8.8 8.8 6.7 6.7 6.7 6.7 7.4 7.4 7.4 7.4 4.7 4.7 4.7 4.7 12.1 12.1 12.1 12.1

DSO

18.8 65.0 3.1 - 7.8 10.8 20.9 - 23.7 22.3 20.8 18.5 8.2 22.1 147.0 61.4 153.4 191.9 235.1 15.9 18.1 19.9 28.9 23.3 25.8 37.0 110.8 50.9 160.7 122.5 86.7 25.2 26.9 27.5 43.6 63.3 76.2 91.1 76.0 41.9 50.5 41.5 71.9 42.2 76.8 82.4 71.0 17.7 45.2 55.4 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

18.8 65.0 3.1 - 7.8 10.8 20.9 - 23.7 22.3 20.8 18.5 8.2 22.1 147.0 61.4 153.4 191.9 235.1 15.9 18.1 19.9 28.9 23.3 25.8 37.0 110.8 50.9 160.7 122.5 86.7 25.2 26.9 27.5 43.6 63.3 76.2 91.1 76.0 41.9 50.5 41.5 71.9 42.2 76.8 82.4 71.0 17.7 45.2 55.4 -

Финансовый цикл

18.8 65.0 3.1 - 7.8 10.8 20.9 - 23.7 22.3 20.8 18.5 8.2 22.1 147.0 61.4 153.4 191.9 235.1 15.9 18.1 19.9 28.9 23.3 25.8 37.0 110.8 50.9 160.7 122.5 86.7 25.2 26.9 27.5 43.6 63.3 76.2 91.1 76.0 41.9 50.5 41.5 71.9 42.2 76.8 82.4 71.0 17.7 45.2 55.4 -

Все данные представлены в валюте USD